F18.259
Inhalant dependence with inhalant-induced psychotic disorder, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant dependence with inhalant-induced psychotic disorder (ICD-10 code F18.259) describes a condition where an individual is dependent on inhalant substances, which are often used for their psychoactive effects. This dependence can lead to episodes of psychosis—altered mental states that include hallucinations, delusions, or disorganized thinking—that are directly linked to inhalant use. While inhalants might provide temporary effects like euphoria or sedation, their use can escalate into serious mental health issues and physical health problems. This condition requires careful assessment and management by healthcare professionals.
Causes & Symptoms
Clinical Causes: Repeated use of inhalant substances such as solvents, aerosols, gases, or nitrates Genetic predisposition or family history of substance use disorder Psychosocial factors such as stress, peer pressure, or environmental influences Underlying mental health conditions like depression or anxiety that lead to self-medication Lack of awareness about the risks associated with inhalant use
Key Symptoms: Dependence on inhalants characterized by cravings and withdrawal symptoms Episodes of psychosis including hallucinations or paranoid delusions Behavioral changes such as neglecting responsibilities or social withdrawal Impaired coordination or motor skills Difficulty concentrating or memory problems Physical symptoms like dizziness, nausea, or headaches during or after inhalant use Mood swings or agitation
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive medical and psychiatric evaluation, including a detailed history of inhalant use and mental health symptoms. Healthcare providers may perform physical examinations, neurological assessments, and laboratory tests to rule out other causes. Mental health professionals use criteria outlined in diagnostic manuals to confirm the presence of dependence and psychotic symptoms linked to inhalant use. It is essential to distinguish this condition from other psychotic disorders or substance use issues to determine appropriate treatment pathways.
Treatment Protocols: Effective management of inhalant dependence with inhalant-induced psychotic disorder involves several approaches:
Clinical Advice & FAQs
Billing Guidance
Is F18.259 a billable ICD-10 code?
Yes, F18.259 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.259?
Clinical documentation must specify the nature of Inhalant dependence with inhalant-induced psychotic disorder, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference